ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
vTv Therapeutics Inc

vTv Therapeutics Inc (VTVT)

14,05
0,57
( 4,23% )
Aktualisiert: 19:24:21

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
14,05
Gebot
13,50
Fragen
14,06
Volumen
7.366
13,5001 Tagesbereich 14,07
7,38 52-Wochen-Bereich 30,99
Marktkapitalisierung
Handelsende
13,48
Handelsbeginn
13,86
Letzte Trade
2
@
13.85
Letzter Handelszeitpunkt
19:24:14
Finanzvolumen
US$ 100.225
VWAP
13,6065
Durchschnittliches Volumen (3 Mio.)
27.907
Ausgegebene Aktien
3.189.606
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,13
Gewinn pro Aktie (EPS)
-6,35
Erlöse
-
Nettogewinn
-20,25M

Über vTv Therapeutics Inc

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (... vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
vTv Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VTVT. The last closing price for vTv Therapeutics was US$13,48. Over the last year, vTv Therapeutics shares have traded in a share price range of US$ 7,38 to US$ 30,99.

vTv Therapeutics currently has 3.189.606 shares in issue. The market capitalisation of vTv Therapeutics is US$43,00 million. vTv Therapeutics has a price to earnings ratio (PE ratio) of -2.13.

VTVT Neueste Nachrichten

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER PR Newswire WESTON, Fla., Dec. 9, 2024 WESTON, Fla., Dec. 9...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.050.3571428571431414.295513.46496113.66390863CS
40.86.0377358490613.2515.26213.15922713.89824607CS
120.040.2855103497514.0118.3712.622790715.12493708CS
26-9.23-39.64776632323.2824.8212.12012879515.59256157CS
523.5633.937082936110.4930.997.383563916.33675585CS
156-16.706-54.317856678430.756567.3816958128.89313271CS
260-86.75-86.0615079365100.8205.27.3889155099.6475586CS

VTVT - Frequently Asked Questions (FAQ)

What is the current vTv Therapeutics share price?
The current share price of vTv Therapeutics is US$ 14,05
How many vTv Therapeutics shares are in issue?
vTv Therapeutics has 3.189.606 shares in issue
What is the market cap of vTv Therapeutics?
The market capitalisation of vTv Therapeutics is USD 43M
What is the 1 year trading range for vTv Therapeutics share price?
vTv Therapeutics has traded in the range of US$ 7,38 to US$ 30,99 during the past year
What is the PE ratio of vTv Therapeutics?
The price to earnings ratio of vTv Therapeutics is -2,13
What is the reporting currency for vTv Therapeutics?
vTv Therapeutics reports financial results in USD
What is the latest annual profit for vTv Therapeutics?
The latest annual profit of vTv Therapeutics is USD -20,25M
What is the registered address of vTv Therapeutics?
The registered address for vTv Therapeutics is 251 LITTLE FALLS DRIVE, OAKS PKWY, WILMINGTON, DELAWARE, 19808
What is the vTv Therapeutics website address?
The website address for vTv Therapeutics is vtvtherapeutics.com
Which industry sector does vTv Therapeutics operate in?
vTv Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DWTXDogwood Therapeutics Inc
US$ 20,03
(615,36%)
71,15M
MCTRCTRL Group Ltd
US$ 10,74
(148,04%)
5,49M
DGNXDiginex Ltd
US$ 12,8233
(70,98%)
9M
NITON2OFF Inc
US$ 1,169
(45,22%)
114,34M
NTRBNutriband Inc
US$ 10,20
(38,96%)
1,58M
CHSNChanson International Holding
US$ 0,9286
(-85,26%)
12,13M
ICONIcon Energy Corporation
US$ 0,4777
(-63,53%)
10,79M
JUNSJupiter Neurosciences Inc
US$ 1,402
(-60,84%)
9,84M
BLBXBlackBoxStocks Inc
US$ 3,72
(-32,61%)
4,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 99,76
(-31,44%)
12
HEPAHepion Pharmaceuticals Inc
US$ 0,1696
(25,63%)
261,87M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3242
(1,63%)
124,7M
NITON2OFF Inc
US$ 1,169
(45,22%)
114,34M
RGTIRigetti Computing Inc
US$ 13,375
(-3,85%)
106,99M
NVDANVIDIA Corporation
US$ 145,6699
(-0,95%)
92,61M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock